To determine the etiology of community-acquired pneumonia in the adult population of a defined area, specific antibody responses in paired serum samples, levels of circulating pneumococcal immune complexes in serum samples, and pneumococcal antigen in urine were measured. Samples (304 paired serum samples and 300 acute urine samples) were obtained from 345 patients у15 years old with community-acquired, radiologically confirmed pneumonia, which comprised all cases in the population of 4 municipalities in eastern Finland during 1 year. Specific infecting organisms were identified in 183 patients (including 49 with mixed infection), as follows: Streptococcus pneumoniae, 125 patients; Haemophilus influenzae, 12; Moraxella catarrhalis, 8; chlamydiae, 37 (of which, Chlamydia pneumoniae, 30); Mycoplasma pneumoniae, 30; and virus species, 27. The proportion of patients with pneumococcal infections increased and of those with Mycoplasma infections decreased with age, but for each age group, the etiologic profile was similar among inpatients and among outpatients. S. pneumoniae was the most important etiologic agent. The annual incidence of pneumococcal pneumonia per 1000 inhabitants aged у60 years was 8.0.
blood yield positive results for 4%-24% of hospitalized patients [1, 2] and !1% of outpatients [3] . A variety of indirect microbiological methods are better suited for patients with pneumonia. At present, some investigators rely mainly on Gram's stain and culture of sputum to determine bacterial etiology [4, 5] , whereas others also look for bacterial antigen in sputum, serum, or urine [6] [7] [8] , a serum antibody response [1, [8] [9] [10] [11] , or pneumococcal immune complexes in serum [10, 11] , or exclude sputum findings for fear of contamination [1, 12] . The methods have been validated, but in the absence of a widely applicable reference standard, none is indisputably predictive of the true cause of pneumonia. In contrast, methods to determine viral etiology, including serological methods, are widely accepted.
A further problem is the representativeness of the patients that have been studied. Most etiologic studies have been conducted in hospitals. Fewer have focused on outpatients [13] [14] [15] [16] [17] [18] , patients enrolled through health maintenance organizations [19] [20] [21] [22] , or all cases of pneumonia in the general population [3, [23] [24] [25] [26] [27] . More information is needed, particularly about outpatients, who represent 50%-78% of adult patients with community-acquired pneumonia [3, 24, 26, 28] , for the planning both of empirical therapy in primary care and of vaccination programs.
The aim of the present study was to investigate the etiology of all bacterial and viral cases of community-acquired pneumonia that occurred in the adult population of a defined geographic area. This was possible because a previous prospective study on the incidence of pneumonia obtained paired serum and urine samples from most patients [28] . Some of the microbiological results have been reported [29] . For the present study, the serum samples were retested by use of recently developed methods for identifying Streptococcus pneumoniae and Chlamydia pneumoniae infection, which greatly increased the number of positive findings. Results for the children have been published separately [30] .
PATIENTS AND METHODS

Identification of patients.
All cases of pneumonia that occurred among the population of an industrial town (Varkaus) and 3 rural municipalities (Keitele, Leppävirta, and Pielavesi), Province of Kuopio, eastern Finland, from 1 September 1981 through 31 August 1982 and the case patients were enrolled in the incidence study [28, 29] . On 31 December 1981, the area had 46,979 inhabitants, of whom 38,128 were aged у15 years, 29,755 (15,491 men and 14,264 women) were aged 15-59 years, and 8373 (3208 men and 5165 women) were aged у60 years [31] . All of the municipalities have local primary health care units and small hospitals, but skilled processing of microbiological samples is possible only 53-95 km away at Kuopio University Hospital, Kuopio, which also is the only referral hospital. With regard to the proportion of urban population, age distribution, educational level, sources of living, socioeconomic status, and health care services, the population is representative of that in Finland overall.
During the 12-month study period, all physicians serving the study population reported each case of suspected or confirmed pneumonia (community-, institution-, or hospital-acquired) that occurred in the study area inhabitants and filled out a simple form. All patients were examined at a follow-up visit 2-4 weeks later by a study physician, who completed the data and classified the findings according to predefined criteria. Further cases were identified at autopsy or retrospectively through 2 population-based provincial registers (the hospital discharge register and the register based on death certificates).
The final diagnosis was based on the findings of radiography (available for 97% of all 871 registered cases) or autopsy [28] . Patients having other causes for their findings (such as pulmonary infarction, cardiac failure, or malignancy) without complicating pneumonia either were not registered or were classified at the follow-up visit as having no pneumonia. Of the total of 871 registered episodes, 613 were classified as pneumonia, and of those, 345 episodes were classified as community-acquired pneumonia in adults (age у15 years) and thus provisionally eligible for the present study. Two of the 345 eligible episodes were first identified at autopsy and 6 through the provincial registers. Availability of samples and patient populations in the analyses. Paired serum samples were obtained from 304 (88%) of the 345 eligible episodes and an acute urine sample from 322 (93%). Results of blood cultures (not part of the study protocol) were available for 9 cases. Fifty percent of the acute serum and urine samples were obtained within the first 2 days and 89% within the first week after the onset of symptoms of pneumonia. In 55% of 231 episodes with respiratory symptoms preceding the onset of pneumonia, the acute serum sample was collected within 1 week after the onset of the initial symptoms. Eighty-eight percent of the second serum samples were obtained 2-4 weeks after the acute serum sample was obtained.
For 41 episodes of community-acquired pneumonia (12% of the 345 episodes in adults), either one or both of the serum samples were missing; these episodes were excluded from the main analysis and, consequently, the 8 cases identified at autopsy or in retrospect were also excluded. Twenty-seven (66%) of the 41 excluded episodes were in patients aged у60 years; of these 41 patients, 24 (59%) had у1 of 8 predefined chronic conditions, 31 (76%) were treated in hospital, and 18 (44%) died within 2 weeks after the onset of symptoms. All but 1 of those who died had severe underlying diseases; pneumonia was considered the cause of death for 14 patients.
The patient group in the main analysis consisted of 304 adults with cases of community-acquired pneumonia and paired serum samples; an acute urine sample was also available for 300. Demographic and other characteristics of this group are shown in table 1.
Because of the poor availability of second serum samples in fatal cases, we analyzed separately those who died in comparison with those who survived on the basis of acute-phase serum and urine samples, without examining possible second serum samples. Because 18 of the 19 who died were aged у60 years, only the samples from the 167 patients aged 160 years were included in this analysis (153 acute serum and 151 acute urine samples).
Microbiological methods. The serum samples were stored in 2 aliquots at Ϫ20ЊC until tested on 4 separate occasions (samples were thawed р3 times) from 1984 through 1994 at the National Public Health Institute in Oulu or in Helsinki. Several new serological methods for demonstration of bacterial etiology were developed during this period and used in the study. The criteria for microbiological diagnosis were based on detection of specific antibody response in paired serum samples, detection of pneumococcal immune complexes in one or both of the serum samples, or detection of pneumococcal antigen in urine (samples stored at Ϫ20ЊC). The methods have been reported before [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] 27 cases with viral infection, parainfluenza viruses dominated the pattern, followed by respiratory syncytial viruses and adenoviruses. Influenza was diagnosed in 3 patients and cytomegalovirus infection in 1; none of the patients showed evidence of enterovirus infection. Three patients contracted pneumonia with specific infection twice; pneumococci alone were involved in 5 of the episodes and parainfluenza virus alone in 1.
Mixed infection was found in 49 (16%) of 304 patients with an episode of pneumonia, as follows: infection with 2 organisms, 41 patients; with 3 organisms, 7 patients; and with 4 organisms, 1 patients. The most frequent combinations were pneumococci with chlamydiae, viruses, or M. pneumoniae (table 5), but no statistically significant associations were found between the species or groups of species. Thirty-five percent of the pneumococcal infections were mixed infections; the proportion was 54% for chlamydiae, 47% for M. pneumoniae, and 63% for viruses. The patients with mixed infection did not differ significantly from the other patients in respect of age (table 3) , sex, presence of the predefined chronic conditions, place of treatment, presence of preceding respiratory symptoms, or presence of coexisting extrapulmonary infections (data not shown).
The 2 methods based on detection of circulating immune complexes were the most sensitive of the methods for diagnosing pneumococcal infection (table 6). In 86 (69%) of the 125 pneumococcal infections, the diagnosis was based on 1 of the findings alone and in 39 (31%) on у2 findings. All of the 9 blood cultures yielded negative results. Nine of the 30 C. pneumoniae infections also presented significant findings by Chlamydia group-specific tests: 3 by complement fixation alone, 2 by EIA alone, and 4 by both.
Etiology by age and sex. The overall distribution by age in cases of pneumococcal, chlamydial, and viral infection was consistent with the distribution of all cases of pneumonia by age, with peaks at ∼60-75 years (table 3) . Pneumococcal infection was, however, significantly more frequent among patients aged у60 years (48%) than among patients aged !60 years (35%; ). A trend toward a higher proportion at P p .04 older ages was also found for viral infections, but the difference was not statistically significant. No consistent trends by age were seen for the proportions of H. influenzae, M. catarrhalis, or Chlamydia infections. In contrast, Mycoplasma infection was ). Other differences in the proportions P p .02 of specific infections by sex were not statistically significant (data not shown).
Etiology among patients with and without chronic conditions. Pneumococcal infection was found in 39 (51%) of the 77 patients with у1 of the predefined chronic conditions and 86 (38%) of the 227 patients with no such conditions (P p ; not significant). Nonsignificant trends of the same direction .07 were seen also in the corresponding age-specific pneumococcal analyses (9 (42) 67 (48) 125 (41) Haemophilus influenzae 3 (3) 3 (5) 6 (4) 12 (4) Moraxella catarrhalis
Chlamydia species C. pneumoniae 9 (9) 6 (10) 15 (11) 30 (10) C. psittaci
Total 10 (10) 9 (15) 18 (13) 37 (12) Mycoplasma pneumoniae 24 (24) 2 (3) 4 (3) 30 (10) Viruses Parainfluenza virus 3 (3) 1 (2) 10 (7) 14 (5) Respiratory syncytial virus 1 (1) 2 (3) 3 (2) 6 (2) (6) 17 (12) 27 (9) Any organism identified 57 (56) 34 (55) ditions (27 [12%] of 227 ), but if age was considered, P p .03 the prevalence of Mycoplasma infection was similar in both groups. The proportions of other specific infections were similar among patients with and without the chronic conditions. No associations were found between the specific chronic conditions and specific infections.
Etiology by place of treatment and hospitalization rates. Mycoplasma infection was significantly more frequent among outpatients than among inpatients (14% vs. 5%; ), a P p .02 finding consistent with the accumulation of Mycoplasma infections in young adults, who usually were treated at home (table 7) . Forty-seven percent of inpatients and 37% of outpatients had pneumococcal infection (50% vs. 44% of patients aged у60 years), but neither this nor other differences between inpatients and outpatients were statistically significant. The hospitalization rate was highest for patients infected with chlamydiae (59%), followed by those infected with viruses (52%), with pneumococci (50%), with 11 organism (45%), with unidentified organisms (37%), and with M. pneumoniae (23%). For patients aged у60 years, the hospitalization rate was highest for those infected with chlamydiae (89%), followed by those infected with 11 organism (75%), with viruses (71%), with pneumococci (67%), and with unidentified organisms (52%).
Temporal and geographic distribution. Pneumococcal, H. influenzae, and M. catarrhalis infections were observed throughout the study period. The incidence of Chlamydia, Mycoplasma, and viral infections decreased to nil between July and August 1982, and there was a simultaneous decrease in the overall incidence of pneumonia [27] . 
4 (6) 10 (7) 17 (6) Mycoplasma pneumoniae 14 (14) 2 ( Total, any organism 38 (37) 24 (39) 72 (51) 134 (44) Incidence of pneumonia with evidence of specific infection. The incidence of community-acquired pneumonia with evidence of specific infection was calculated for the most common infecting organisms as cases per 1000 inhabitants per year. This gave the following figures for all adults у15 years of age: infection with pneumococci, 3.3; with chlamydiae, 1.0; with C. pneumoniae, 0.8; with M. pneumoniae, 0.8; and with viruses, 0.7. The age-specific figures for pneumococcus infection (per 1000 per year) were as follows: for inhabitants aged 15-59 years, 1.9 (men, 1.8; women, 2.1) and for patients aged у60 years, 8.0 (men, 15.6; for women, 3.3).
Separate comparison of patients who died and those who survived. Two (20%) of the 10 acute serum samples from the 18 patients у60 years who died and 33 (23%) of the 143 acute serum samples from the 149 survivors in the same age group tested positive for pneumococcal immune complexes. In the same age group, 1 of the 10 urine samples from those who died and 7 (5%) of the 141 urine samples from the survivors tested positive for pneumococcal antigen.
DISCUSSION
This prospective study on the microbial etiology of community-acquired pneumonia in adults presents data for both bacterial and viral pneumonia that are representative of the total population of a defined geographic area, and consequently avoids selection bias. The representativeness of the patients in combination with the uniform sampling and microbiological methods allowed meaningful comparisons between various groups of patients. In contrast to many previous studies, we used serological tests to identify both bacterial and viral infections. Despite these differences, our results confirm many features of the etiology of community-acquired pneumonia that have been demonstrated in previous studies: in particular, the high proportion of patients with pneumococcus infection, and the frequent occurrence of Mycoplasma infection in young adults. C. pneumoniae has only recently been identified as a cause of pneumonia, but in this study, Chlamydia infections ranked next after pneumococcal infection, and C. pneumoniae caused the bulk of them.
When comparing various groups of patients, the greatest practical importance lies in the similarities rather than in the differences. This is exemplified by the proportion of patients with of pneumococcal infection, which increased slightly but significantly with age (table 3) , and was particularly high among elderly men, whereas differences between other groups of patients were statistically nonsignificant trends only. This implies that data on pneumococcal infection from 1 category of adults with community-acquired pneumonia (e.g., patients treated in hospital, otherwise unselected) apply reasonably well to another category of patients that may be hard to study (e.g., outpatients), as well as for the group of adults with communityacquired pneumonia as a whole. Such reasoning has been widely applied but with little formal justification. Only Mycoplasma infection deviated from the general pattern: it was highest among young adults, who were usually treated at home irrespective of the microbial etiology. This exemplifies the dangers of uncritical generalization from studies of hospitalized patients. The high hospitalization rate of patients with Chlamydia infection suggests that pneumonia due to chlamydiae rivals even pneumococcal pneumonia in severity. The significance of mixed etiology has increasingly been appreciated in the literature, particularly in studies that apply new, sensitive diagnostic methods to identify infection with both bacteria and viruses [10, 11, 30] . We identified mixed infection in 16% of episodes of pneumonia. The possibility that some of these were misclassified because of false-positive crossreactions cannot be formally excluded in the absence of a reference standard, that is, direct examination of samples from the infection site. The cutoff values of the assays were, however, rigorously fixed to exclude false-positive results. Previous studies have shown that viral infection may pave the way for bacterial infection [46] . The combinations observed in this study support the possibility that similar mechanisms may be true for other pairs of infecting organisms as well, but we found no specific associations.
As in most pneumonia studies, the etiology remained unidentified in a considerable proportion (40%) of the cases. Because no microbiological methods are 100% sensitive, it is likely that many of these cases were in fact caused by the same organism as those identified. The hospitalization rate among these patients was low, however, suggesting that most of the unidentified organisms caused less severe disease. (The possible contribution of known organisms that we did not look for is discussed below.) The continuous discovery of new causes of pneumonia [47] suggests that entirely unknown causes were also involved.
Of note, the design of the study allowed direct calculation of the incidence of pneumonia with evidence of specific infection, including age-and sex-specific incidences. The incidence of pneumonia with evidence of pneumococcal infection was 14 times higher among inhabitants aged у60 years (8.0 per 1000 per year) than among younger inhabitants (1.9 per 1000 per year), a finding that was mainly due to the extremely high incidence in elderly men.
The epidemiological circumstances during the study are of profound importance for the interpretation of the results. Although there was a sharp local outbreak of pneumonia due to respiratory syncytial virus among children in the same area in the fall of 1981 [30] , we observed no outbreaks in the adults. The declining incidence of pneumonia toward the end of the study in the summer of 1982 [28] , together with the coincident disappearance of Chlamydia, Mycoplasma, and viral infections, raises the question of whether there in fact were several slowly fading epidemics, for example in the municipality of Leppä-virta, where Mycoplasma infection was more frequent than elsewhere. On the other hand, it is only natural that the incidence of pneumonia diminishes in the summer [19] .
The paucity of influenza was unexpected but consistent both with countrywide annual laboratory records [48] and studies of pregnant Finnish women. Paired serum samples collected before and after the annual influenza season from pregnant women representing the whole country showed antibody responses to influenza A virus in only 0.7% of 291 women in the winter of 1981-1982 and 1.5% of 674 women in the previous winter, whereas 25% responded in 1979 and 22% in 1982 -1983 (R. Pyhälä, personal communication, 1998 . This situation was also likely to reduce the incidence of bacterial pneumonia, a common complication of influenza. The countrywide occurrence of Mycoplasma infection, on the other hand, was almost 70% above the average for the years 1970-1994 (M. Kleemola, unpublished data). Data from other parts of eastern Finland indicate that the study fell in an interepidemic period for C. pneumoniae [49] . The 3 main challenges were the representativeness of the patient sample, the availability of specimens for all groups of patients, and the microbiological methods used. Essentially every case of community-acquired pneumonia that occurred in the adult residents of the study municipalities was identified [28, 29] , paired serum samples were available from 88% of them, and all of the patients with paired serum samples were included in the main analysis. The etiologic results thus well represent all cases in the study population during the study period. The only exceptions were the patients who died within 2 weeks, because most of them were excluded from the main analysis that required 2 serum samples. In the separate analysis based on the acute serum and urine samples only, we could compare the prevalence of pneumococcal infection among these patients and survivors of the same ages. The results suggest that pneumococcal infection was about as common among the patients who died as among those who survived.
The infecting organisms we sought included all those generally known to be frequent causes of community-acquired pneumonia in Finland [9, 10, 50] . Legionella and Coxiella burnetii were not included, because all available data suggest that they were and still are very rare causes of pneumonia in this country. From 0.8% to 1.4% of patients have been positive for Legionella, as determined by culture on selective media, direct immunofluorescence, or antibody response (detected by use of indirect immunofluorescence technique) ( [10] ; M.-L. Katila, personal communication, 1998). Only 52 Legionella infections were identified in a countrywide survey of laboratory records from 1982 through 1992 (population 5 million); most of the patients were immunosuppressed or had traveled abroad [51] . Between 1995 and 1999, 46 Legionella infections and no Coxiella infections were reported by the laboratories to the National Register of Communicable Diseases [52] . Seroepidemiological surveys of human and animal serum samples [53] (R. Heinonen, personal communication, 1998) and a study including 152 Finnish patients with pneumonia [54] have also been negative for Coxiella.
We chose to use serological methods, which are ideal for epidemiological purposes because samples can be collected from most patients and be processed later in a competent reference laboratory by a variety of methods. In contrast to sputum samples, they neither require ability of the patient to produce a valid sample nor skilled processing in the local laboratory, nor are they vulnerable to transport or previous antibiotic therapy. In most cases, the acute serum sample was collected within 7 days after the onset of symptoms and the second serum sample 2-4 weeks later. This was optimal for all organisms except C. pneumoniae, to which antibodies in some cases develop late [45] . Blood for culture, sputum samples, throat swabs, or samples obtained by invasive procedures could not be collected as part of our study protocol, because they were impracticable in most of the small health care units where 95% of our patients were examined. The 9 cultures of blood performed at the discretion of the attending physicians had negative results.
To obtain data useful for pneumococcal vaccination policies, we focused especially on pneumococci. The use of multiple methods for detecting pneumococci, among them 2 methods based on detection of antibodies in immune complexes, substantially increased the sensitivity of the pneumococcal diagnostics. In 48% of all cases classified as pneumococcal infection, one or both of the methods based on immune complexes presented significant findings already in the first serum sample, and these methods also enabled the separate comparison of those who died with those who survived. The serum samples were thawed up to 3 times for bacterial serology, but we always retested some serum samples from earlier series as a part of the standard procedure, and 2-3 freezing-thawing rounds were shown to have no effect on IgG antibody levels or immune complex values. Our EIA results are based on the calculation of end point titers from antibody dilution curves, not on the classical estimation of end point titers from serial 2-fold dilutions requiring a у4-fold change in titer as diagnostic. By testing paired serum samples from healthy persons, we have shown that a 2-fold increase in titer is diagnostic when, for example, purified pneumococcal proteins are used and a 3-fold increase is diagnostic when, for example, whole bacterial cells are used as antigen in EIA [55] .
The identification of C. pneumoniae infection was, as in other studies [10, 11] , based on an increase in serum antibody concentration or detection of specific IgM antibodies remaining after absorption of IgG to remove possible false-positive results due to rheumatoid factor. Complement fixation alone was used for diagnosis of Mycoplasma and viruses. Although less sensitive than some newer methods, complement fixation is still widely used as the sole method for both of these purposes [9, 10, 18, 24, 29, 56] . A poor response on complement fixation testing has been associated with high level of preinfection antibodies (titer у32) [57] , but this was not a problem among our patients; for example, only 1% had such high initial titers against influenza A or B viruses.
A potential problem with serological tests is that a patient's ability to form antibodies may be poor. Although this means that serological methods will yield an underdiagnosis, it was not likely to be critical in this population of predominantly immunocompetent adult patients. Elderly persons, including those у85 years of age, have been shown to develop good antibody responses to pneumococcal polysaccharides [58] . The finding of high proportions of patients with identified etiology among elderly patients treated in hospital (table 7) and patients with chronic conditions also speaks against substantial problems of this kind.
The etiologic profile among our hospitalized patients (table  7) accords well with the combined information from previous studies of community-acquired pneumonia in essentially unselected adult patients admitted to hospital. Pneumococci have generally accounted for 25%-55% (range, 15%-76%) of the cases. H. influenzae has accounted for 3%-11%, M. catarrhalis for 1%-6%, chlamydiae for 1%-46%, C. pneumoniae for 6%-43%, M. pneumoniae for 2%-29% (generally !10%), viruses for 7%-18%, and other organisms for 3%-26% [1, 2, 4, [6] [7] [8] [9] [10] [11] . The proportion of cases with no identified etiology has usually been 20%-40% (range, 3%-49%). The diverging results are partly related to endemic and epidemic causes and partly to the microbiological methods. The bacterial methods are particularly critical: the results of blood cultures alone or findings from sputum samples screened for cellular content give low prevalences, and serological methods give intermediate prevalences, whereas the highest prevalences come from studies accepting findings from unselected sputum samples. C. pneumoniae has been shown as one of the most important causes in studies in which it has been sought by species-specific methods [10, 11] .
In previous studies of adult outpatients, pneumococcal infection has been diagnosed in 9%-13% of patients [13] [14] [15] , which is significantly lower than the 37% found by us. H. influenzae infection has been found in 0%-12%, C. pneumoniae infection in 3%-15%, mycoplasma infection in 13%-37%, and viral infection in 6%-21% of outpatients [13] [14] [15] [16] [17] [18] ; our figures fall within these ranges (table 7) . Two of the reports allowed comparison of inpatients to outpatients [14, 17] . In one of them, pneumococcal infection was reported in 15% of inpatients and 13% of outpatients [14] . As in the present study, M. pneumoniae was more frequent among outpatients than among inpatients (13% [14] and 33% [17] vs. 3%). Trends for Chlamydia and viral infections were not statistically significant. Reports from health maintenance organizations in the United States show between 7% and 20% prevalences of pneumococcal infection in adult patients with pneumonia [20] [21] [22] . In longterm studies from Seattle, C. pneumoniae infection has been found in 7%, Mycoplasma infection in 14%, and viral infections in 21% of adult patients with pneumonia [19, 59] . Population-based studies [3, 23, 24, 26] are compared in table 8. Pneumococcal infection has been diagnosed in 12%-36% of patients (vs. 41% of our patients) and H. influenzae infection in 0%-27% (vs. 4% of our patients). Again, the widely varying figures are more likely to reflect differences in the bacteriological methods than true differences in the etiology. The methods for identifying C. pneumoniae, M. pneumoniae, and viral infections were somewhat more uniform, and these results may thus reflect different epidemiological situations. Two Finnish vaccination trials conducted among the elderly population of Varkaus and northern Finland showed that pneumococci were implicated in 35%-52% of pneumonia cases in patients aged у60 years [25] or aged у65 years [27] (data not shown in the table), compared with 48%, as determined by use of similar serological methods, of cases in our patients aged у60 years. The etiologic findings for younger adult patients in the present study resembled those for the older children enrolled in our connected study; the proportions of Mycoplasma, Chlamydia, and respiratory syncytial virus infections were, however, higher among children [30] . The incidence of pneumococcal pneumonia among the elderly (the main target group for vaccination according to US recommendations [60] ) was 1.2 per 1000 person-years in San Francisco (among persons у45 years) [21] and 8.6 per 1000 person-years in Varkaus [25] , compared with 8.0 per 1000 inhabitants per year in the present study.
Trying to formulate a precise numerical synthesis of the true etiologic pattern of community-acquired pneumonia among adults living in developed countries from published studies is unsuccessful, because of differences in patient selection, exclusion of patients of certain ages or with certain underlying conditions, varying endemic and epidemic conditions, missing samples, the effect of previous antibiotic therapy, and especially the heterogeneous microbiological methods used. We believe that our results, which were based on unbiased patient selection, uniform sampling in all groups of patients, and a broad selection of serological methods, form an essential adjunct to present knowledge. They can be used to guide the treatment and prevention of community-acquired pneumonia in adults, especially in Finland and other developed countries with a temperate climate. In areas with important endemic or epidemic causes of infection (such as legionellae and C. burnetii) or predisposing conditions (most notably HIV infection), these should be taken into account.
For therapeutic purposes, the most interesting of our results are the etiology in the patients treated at home, for whom relatively few data are available, and the comparison between inpatients and outpatients. The differences were principally related to age. Pneumococcal infection was diagnosed in 30%-50% of all groups of patients, emphasizing that empirical antibiotic therapy should always be active against pneumococci. More than 20% of the patients were infected with chlamydiae or M. pneumoniae, even in the absence of obvious local epidemics. Therefore, it is often necessary to choose treatments that are active against these organisms as well as pneumococci, especially for patients !45 years of age, of whom one-third had Chlamydia or Mycoplasma infection.
Vaccines are available against influenza and pneumococci, and new improved pneumococcal vaccines are currently under development [61] . Our age-specific results about the incidence of pneumococcal pneumonia are particularly useful for the consideration of the need for pneumococcal vaccination. Both the incidence of and the hospitalization rate for pneumococcal pneumonia were very high in the population aged у60 years, inevitably leading to considerable costs of the disease and, conversely, savings obtainable through efficient vaccination programs.
